vimarsana.com
Home
Live Updates
Medios Group - Breaking News
Pages:
5
6
7
8
9
10
11
Latest Breaking News On - Medios group - Page 4 : vimarsana.com
Investegate |Medios AG Announcements | Medios AG: Medios AG continues record course: Strong growth in the first half of 2022
Investegate announcements from Medios AG, Medios AG continues record course: Strong growth in the first half of 2022
United kingdom
Matthias gaertner
Claudia nickolaus
Deutsche boerse
Newco pharma group
Specialty pharma solutions
Medios group
Patient specific therapies
Newco pharma
Prime standard
Supervisory board
Chief executive officer
Executive board
Berenberg european conference
Pennyhill park
Investor relations
Medios AG continues record course: Strong growth in the first half of 2022
11.08.2022 Medios AG continues record course: Strong growth in the first half of 2022 | Medios AG | News | Nachricht | Mitteilung
United kingdom
Matthias gaertner
Claudia nickolaus
Deutsche boerse
Newco pharma group
Specialty pharma solutions
Medios group
Patient specific therapies
Newco pharma
Prime standard
Supervisory board
Chief executive officer
Executive board
Berenberg european conference
Pennyhill park
Investor relations
DGAP-News: Medios AG: Revenue and earnings at record levels in the first quarter
DGAP-News: Medios AG: Revenue and earnings at record levels in the first quarter
Matthias gaertner
Newco pharma
Claudia nickolaus
Hauck aufh
Newco pharma group
Specialty pharma solutions
Acquisition of newco pharma group
Deutsche bank
Medios group
Patient specific therapies
Nonfinancial consolidated statement
Specialty pharma
Euro finance small cap conference
Access berlin conference
Annual general meeting
Year financial report
Investegate |Medios AG Announcements | Medios AG: Record year 2021 and positive outlook for 2022
Investegate announcements from Medios AG, Record year 2021 and positive outlook for 2022
Matthias gaertner
Pharma gmb
Claudia nickolaus
Newco pharma group
Specialty pharma solutions
Medios group
Annual report
Cranach pharma gmbh
Pharmaceutical supply
Cranach pharma
Patient specific therapies
Specialty pharma
Investor relations
Regulated market
Frankfurt stock exchange
Prime standard
DGAP-News: Medios AG: Record year 2021 and positive outlook for 2022
DGAP-News: Medios AG / Key word(s): Annual Results/Forecast Medios AG: Record year 2021 and positive outlook for 2022 29.03.20.
Matthias gaertner
Pharma gmb
Newco pharma group
Specialty pharma solutions
Medios group
Annual report
Cranach pharma gmbh
Pharmaceutical supply
Cranach pharma
Patient specific therapies
Specialty pharma
Investor relations
vimarsana © 2020. All Rights Reserved.